Mycobacterium tuberculosis Beijing genotype, northern Malawi

Area of Science:

• Epidemiology
• Infectious Diseases
• Genomics

Background:

• Tuberculosis (TB) remains a global health challenge.
• Understanding the genetic diversity of Mycobacterium tuberculosis is crucial for public health interventions.
• The Beijing genotype is a globally prevalent lineage of M. tuberculosis.

Purpose of the Study:

• To investigate the epidemiological trends of the Beijing genotype of tuberculosis in Malawi over a 7-year period.
• To compare the drug susceptibility, clinical characteristics, and outcomes of Beijing genotype TB with non-Beijing genotypes.

Main Methods:

• A population-based study was conducted over 7 years in Malawi.
• Tuberculosis cases were analyzed for genotype, specifically identifying the Beijing genotype.
• Data on drug susceptibility, contact history, TB type, and case-fatality rates were collected and compared.

Main Results:

• The proportion of tuberculosis cases attributed to the Beijing genotype showed an increase over the study period.
• All identified Beijing genotype strains were found to be fully drug-sensitive.
• No significant differences were observed in contact histories, TB type, or case-fatality rates between Beijing and non-Beijing genotype TB cases.

Conclusions:

• The Beijing genotype is emerging as a significant proportion of TB cases in Malawi.
• Despite its increasing prevalence, the Beijing genotype in this study did not exhibit increased drug resistance or distinct clinical impact compared to other genotypes.
• Continued surveillance of TB genotypes and their clinical implications in Malawi is warranted.